Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-19

FDA Approved: NAPHCON A — Supplemental Application (Alcon Laboratories, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for NAPHCON A (napahzoline hydrochloride and pheniramine maleate) from Alcon Laboratories, Inc. The product is used …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NAPHCON A (Naphazoline hydrochloride and pheniramine maleate)

Snippet

SUPPL AP for NAPHCON A (NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE)